Kenvue Q3 FY2026: sales up 3.2%, adjusted EPS of $0.29 misses
Kenvue grew net sales 3.2% to $3.886 billion and lifted adjusted EPS 4% to $0.29, but that was roughly a penny under the $0.3004 consensus, and management gave no guidance at all because of the pending Kimberly-Clark deal. Read this as a steady operating quarter wrapped in transaction fog: margins improved, cash generation jumped, and the forward view is deliberately blank.
1 · Expected vs. Actual
Free preview belowAdjusted diluted EPS of $0.29 was up 4% from $0.28 but below the $0.3004 consensus, a miss of about $0.01, or 3.5%. GAAP diluted EPS was $0.22 versus $0.21, held back by an effective tax rate of 29.4% against 24.3% a year earlier. The GAAP-to-adjusted gap is mostly intangible amortization, restructuring and $28 million of costs tied to the Kimberly-Clark transaction.
Net sales of $3.886 billion rose 3.2% from $3.764 billion, the fourth straight quarter of growth. Organic sales rose 2.9%, made up of 1.6% volume and 1.3% price/mix, so this was volume-led rather than purely priced. Self Care did the heavy lifting at $1.656 billion, up 5.9%, while Skin Health and Beauty was essentially flat at $1.039 billion.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-02
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.